These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15894429

  • 1. Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.
    Richards S.
    Cancer Treat Rev; 2005 Jun; 31(4):332-5. PubMed ID: 15894429
    [No Abstract] [Full Text] [Related]

  • 2. Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia.
    Tsimberidou AM, Keating MJ, Giles FJ, Wierda WG, Ferrajoli A, Lerner S, Beran M, Andreeff M, Kantarjian HM, O'Brien S.
    Cancer; 2004 Jun 15; 100(12):2583-91. PubMed ID: 15197800
    [Abstract] [Full Text] [Related]

  • 3. Chronic lymphocytic leukaemia: current first-line therapy.
    Carney DA, Mulligan SP.
    Intern Med J; 2009 Jan 15; 39(1):44-8. PubMed ID: 19290981
    [Abstract] [Full Text] [Related]

  • 4. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
    Prescrire Int; 2005 Feb 15; 14(75):3-5. PubMed ID: 15747447
    [Abstract] [Full Text] [Related]

  • 5. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S.
    Acta Haematol Pol; 1995 Feb 15; 26(3):263-8. PubMed ID: 8525771
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Successful treatment for advanced and refractory chronic lymphocytic leukemia with fludarabine phosphate].
    Takeuchi M, Tada A, Soda R, Takahashi K.
    Rinsho Ketsueki; 1997 Sep 15; 38(9):792-4. PubMed ID: 9364873
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
    O'Brien S, Moore JO, Boyd TE, Larratt LM, Skotnicki A, Koziner B, Chanan-Khan AA, Seymour JF, Bociek RG, Pavletic S, Rai KR.
    J Clin Oncol; 2007 Mar 20; 25(9):1114-20. PubMed ID: 17296974
    [Abstract] [Full Text] [Related]

  • 15. Fludarabine.
    Med Lett Drugs Ther; 1991 Sep 20; 33(853):89-90. PubMed ID: 1886506
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L, Andrýs C, Krejsek J, Belada DZ, Zák P, Siroký O, Malý J.
    Vnitr Lek; 2007 Nov 20; 53(11):1171-6. PubMed ID: 18277626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fludarabine for chronic lymphocytic leukemia.
    Marchetti M, Barosi G, Liberato LN.
    N Engl J Med; 2001 Apr 12; 344(15):1166-7; author reply 1167-8. PubMed ID: 11302140
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.